Karbocistein Alpha-Medical (Carbocisteine)

Carbocisteine works by breaking disulfide bonds in mucoproteins, which reduces the viscosity and elasticity of airway secretions. This chemical alteration makes the mucus less tenacious, allowing ciliary action and coughing to clear it more effectively and improve airway patency.

The appropriate dose of carbocisteine is determined by the prescribing clinician based on the patient’s specific condition, severity, age and renal or hepatic function. Dosage recommendations are provided in the product’s prescribing information and should be followed exactly as directed by a healthcare professional.

Safety data for carbocisteine in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any temperature‑controlled requirements) and the necessary import documentation.

Both carbocisteine and N‑acetylcysteine thin mucus, but they act via different mechanisms. Carbocisteine cleaves disulfide bonds within mucoproteins, whereas N‑acetylcysteine provides a sulfhydryl group that reduces disulfide linkages and also has antioxidant properties. Clinical choice often depends on patient tolerance, specific indication and physician preference.

Store the product at room temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture, direct sunlight and extreme temperatures. Do not refrigerate or freeze unless the label specifically indicates a different requirement.

The medication is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the specific instructions provided by their prescriber or the product label to ensure optimal absorption and effectiveness.

Serious adverse reactions, although rare, include severe allergic responses such as rash, urticaria or anaphylaxis, significant liver enzyme elevation or hepatitis, and severe gastrointestinal bleeding. Patients should seek immediate medical attention if they experience any signs of these conditions.

Carbocisteine should be avoided in individuals with known hypersensitivity to carbocisteine or any excipients in the formulation. It is also contraindicated in patients with severe renal or hepatic impairment unless a specialist determines that benefits outweigh risks, and it should be used with caution in those with a history of bronchospasm.